Ken Griffin Deciphera Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $2.05 Million - $2.62 Million	-150,738 Reduced 57.69%	110,550 $1.74 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $265,529 - $434,406	26,264 Added 11.18%	261,288 $4.21 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $2.93 Million - $3.64 Million	235,024 New	235,024 $2.99 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $693,962 - $1.08 Million	48,665 Added 49.89%	146,211 $2.26 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $1.53 Million - $1.96 Million	-103,098 Reduced 51.38%	97,546 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $567,387 - $927,161	45,831 Added 29.6%	200,644 $3.71 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $220,744 - $338,749	-24,231 Reduced 13.53%	154,813 $2.04 Million
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $1.02 Million - $1.64 Million	147,835 Added 473.69%	179,044 $1.66 Million
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $211,118 - $1.02 Million	-27,418 Reduced 46.77%	31,209 $304,000
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $2.79 Million - $3.91 Million	-105,334 Reduced 64.24%	58,627 $1.99 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $5.17 Million - $7.57 Million	157,956 Added 2630.41%	163,961 $6 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $932,281 - $1.31 Million	-23,082 Reduced 79.36%	6,005 $269,000
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $6.86 Million - $8.76 Million	-132,414 Reduced 81.99%	29,087 $1.66 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $6.9 Million - $9.17 Million	157,616 Added 4057.04%	161,501 $8.29 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $15.7 Million - $27.5 Million	-422,492 Reduced 99.09%	3,885 $232,000
Q1 2020 May 15, 2020	BUY	$33.63 - $69.4 $13.9 Million - $28.7 Million	414,174 Added 3394.03%	426,377 $17.6 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $9.98 Million - $22 Million	-314,877 Reduced 96.27%	12,203 $760,000
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $759,755 - $1.48 Million	38,083 Added 13.18%	327,080 $11.1 Million
Q2 2019 Aug 14, 2019	SELL	$21.05 - $26.21 $1.6 Million - $1.99 Million	-76,019 Reduced 20.83%	288,997 $6.52 Million
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $3.56 Million - $5.1 Million	-172,427 Reduced 32.08%	365,016 $0
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $4.24 Million - $8.02 Million	221,981 Added 70.37%	537,443 $11.3 Million
Q3 2018 Nov 13, 2018	BUY	$33.57 - $42.1 $9.67 Million - $12.1 Million	287,991 Added 1048.35%	315,462 $0
Q2 2018 Aug 10, 2018	BUY	$20.06 - $44.95 $22,748 - $50,973	1,134 Added 4.31%	27,471 $0
Q1 2018 May 11, 2018	BUY	$20.04 - $29.71 $527,793 - $782,472	26,337 New	26,337 $528,000
Q4 2017 Feb 09, 2018	SELL	$16.54 - $24.2 $4.32 Million - $6.33 Million	-261,436 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$17.65 - $18.99 $4.61 Million - $4.96 Million	261,436	261,436 $4.97 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account